# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Zuanic & Associates analyst Pablo Zuanic initiates coverage on Tilray Brands (NASDAQ:TLRY) with a Neutral rating.
The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven...
A recent study led by Dr. Erika Rosen of the Alcohol Research Group and RTI International and published in the Journal of Studi...
Explore the rapid growth of the medical cannabis packaging market, projected to reach $117.2 billion by 2032. Read now!
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Wednesday the Good Supply launch of its 'Summer Shareability...
This week's Viridian Valuation Tracker investigates the valuation metrics of Canadian cultivation and retail companies with...
Lawmakers in Germany have set a maximum allowed limit of THC – tetrahydrocannabinol, a psychoactive substance found in the cann...